Pharmaceutical, Webinars

Supporting Earlier Delivery-System Decisions Through a USP <382>-Aligned Approach

8 Sep 2026

Early delivery-system decisions can influence the success of injectable drug development programs. This article explores a USP <382>-aligned system-level approach developed by Aptar Pharma and Stevanato Group, evaluating prefilled syringe, plunger, and rigid needle shield configurations to generate performance and integrity

By Crystal Salvans, Aptar Pharma, Sara Masucci, Stevanato Group
$resourceAuthor.title, $resourceAuthor.title
Share
USP382_newsroom_header_safezone_1920x1080.jpg

Learn more about Aptar Pharma Expertise
in Injectable Drug Delivery

 

This Might Also Be of Interest

02 Oct 2026
How Patient-Centered Design Can Transform Nasal Health
Pharmaceutical Publications
23 Sep 2026
Why Aptar Pharma's BiDose™? Expanding Opportunities in Systemic Nasal Drug Delivery
Pharmaceutical Blogs
22 Sep 2026
Human Imaging and the Future of Nose-to-Brain Drug Delivery
Pharmaceutical Publications
24 Jul 2026
Aptar Pharma x Dianosic: Innovating Intranasal Drug Delivery
Pharmaceutical Webinars